We next sought to determine if acquisition of a RAC1 mutation resulted in dabrafenib resistance in the PDX.008.CL cells, similar to the patient’s metastatic mediastinal tumor at progression. This evidence concerns the gene RAC1 and neoplasm of mediastinum.